Disruptive targeted drug delivery system via synergistic combination of intelligent DNA molecular machines and gated mesoporous nanoparticles

Projektinformationen

SMARTRIOX

ID Finanzhilfevereinbarung: 811744

DOI 10.3030/811744

Projekt abgeschlossen

EK-Unterschriftsdatum 25 Mai 2018

Startdatum 1 Juni 2018

Enddatum 31 Oktober 2021

Finanziert unter

• INDUSTRIAL LEADERSHIP - Innovation In SMEs

Gesamtkosten € 2 847 667,50

EU-Beitrag € 1 993 367,25

Koordiniert durch

TRIOX NANO LTD
Israel

Leistungen

Websites, patent fillings, videos etc. (1)

Project Web page

It will contain information about the project’s Coordinator and Objectives and Stakeholders. The website will be updated with new information on Meetings, Deliverables and main Milestones. Website visitors will be able to subscribe to the TXN770 Newsletter.